SORT BY Relevancy
On the Wednesday, October 1st 2014 broadcast at 2PM Pacific/5PM Eastern our special guest is Florence Comite, MD. Dr. Comite is an endocrinologist specializing in the emerging field of 'precision medicine'.
More about Dr. Comite:
Dr. Florence Comite is a noted Manhattan endocrinologist. Dr. Comite graduated from Yale University School of Medicine in 1976 with awards for original research and continued at Yale with a residency in Medicine. She then completed a fellowship in Reproductive Endocrinology (multidisciplinary training incorporating Medicine, Pediatrics, Gynecology and Andrology) at the National Institute of Child Health and Human Development (NICHD). She remained at NIH as a Senior Clinical Associate until 1984 and joined the Yale faculty in 1985, where she continued her clinical efforts and research focused on Hypothalamic – Pituitary – Gonadal function in men, women, and children. From 1988 to 1998, Dr. Comite founded and directed Women’s Health at Yale as an Associate Professor in Endocrinology in the Department of Internal Medicine and Pediatrics as well as Reproductive Endocrinology in the Department of Obstetrics and Gynecology. From 1994 to 1995, Dr. Comite was a senior Clinical and Research Advisor to the NIH Offices of Alternative Medicine (OAM) and Research in Women’s Health (ORWH). Dr. Comite is a member of the Age Management Medicine Group, conference planning committee, and has served on numerous advisory councils and committees with the NIH, the Egyptian Ministry of Health, the International Spa Association, the Institute of Medicine.
For complete bio, click here.
Join is for an informative chat!
Ben Weintraub Ph.D. hosts this discussion with Dr. Antonio Jimeno. Dr. Jimeno is an assistant professor of Oncology and the Director of Developmental Therapeutics and Pharmacodynamic Laboratory at the University of Colorado Cancer Center. One of the biggest unknowns in oncology is how quickly we will be able to make better choices about the use of targeted cancer agents using predictive biomarkers. Therefore, the topic of today’s call is the state-of-the-art biomarkers in cancer therapy. You can hear the opening few minutes of this call. If you would like to join or start a discussion on this topic please join us at http://inthought.ning.com/.
For decades, debate has raged over whether fibromyalgia (FM) is a real medical disease. Dr. Bruce Gillis talks about research at the University of Illinois at Chicago that shows what's happening with the immune system in FM. Measurable biomarkers from this landmark study resulted in the first clinical test for fibromyalgia (Fm/a Test). Dr. Gillis is a family practice physician whose company (EpicGenetics) is central to the fulfillment of the laboratory work necessary to unequivocally diagnose FM. The study conclusion showed that cytokine responses to mitogenic activators or PBMC isolated from patients with FM were significantly lower than those of healthy individuals, implying that cell-mediated immunity is impaired in FM patients. This novel cytokine assay revealed unique and valuable immunologic traits, which, when combined with clinical patterns, can offer a diagnostic methodology.
This scientific test offers the possibility for people who suspect they have fibromyalgia but have never been diagnosed to have a way to find out if their symptoms are actually fibromyalgia. Dr. Gillis discusses the study, how it was done, as well as a follow-up study that was presented at the 2013 American College of Rheumatology meeting. This ground breaking research is poised to change the way fibromyalgia is viewed by the medical community and help to bring closure to skepticism experienced by people with fibromyalgia. For more information: http://www.fmcpaware.org/fm-a-real-medical-disease
You’ve seen it on TV. The scientist puts a drop of some mysterious substance in a machine that swirls and twirls and out the other end comes a frequency graph that magically identifies the substance as some snake venom, blood type or biochemical component.
But where is your energy body? Can you drink a frequency? Can frequency make you sick, make you fat, cause you to feel high or depressed?
Einstein proclaimed that there are no solids. We exist in a universe completely made of energy (as measured as frequency). Our body is energy, our thoughts, our spirit can all be measured BioAcoustically as frequency/energy.
Join us to learn how from birth to death we use frequency to express our need and emotions. Imagine a future in which our individual frequency is our only identification; where the use of frequency based biomarkers contained within our voice can be used to keep us healthy and emotionally balanced.
Frequency is the basis of our universe. Frequency is all there is.
Sound Health Options
E-Specail >> BioDiet Class
Dr. Ian Thompson is Professor, Glenda and Gary Woods Distinguished Chair in GU Oncology at The University of Texas Health Science Center, San Antonio. Dr. Ian Thompson received his undergraduate degree from West Point and his M.D. degree from Tulane University. After a Residency in Urology in San Antonio, he completed a fellowship in Urologic Oncology at Memorial Sloan Kettering Cancer Center. Dr. Thompson has published over 400 scientific papers, several dozen book chapters, and has edited five textbooks in medicine and surgery. He currently serves as Vice-Chair of the Early Detection Research Network of the National Cancer Institute and is Chair of the Genitourinary Committee of the Southwest Oncology Group, the largest clinical trials organization supported by the National Cancer Institute. Dr. Thompson is the Principal Investigator of the San Antonio Center for Biomarkers Of Risk of Prostate Cancer. This cohort study, with up to 8 years of followup, currently follows over 3,600 men for development of prostate cancer and has been the source of many recent important developments in the early detection of prostate cancer.
Our prostate cancer panels are conducted in association with Prostate Cancer International and Prostate Cancer Foundation.
RSVP here (or) mail email@example.com
We were honored to feature Dr. Laurence Klotz, an acknowledged authority on active surveillance for the management of low-risk prostate cancer. Dr. Klotz is Professor in the Department of Surgery, University of Toronto Division of Urology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Dr. Klotz and panelists discussed evidence supporting value of active surveillance as a management strategy for men who are diagnosed with low- or very low-risk forms of prostate cancer. Dr. Klotz spoke particularly about factors that are key to the high-quality implementation of active surveillance, including accumulating evidence that true Gleason 6 disease is not associated with any significant risk for metastasis, importance of early identification of patients who do, in fact, have real risk for disease progression over time, are therefore not good candidates for active surveillance, and managing these patients, evolving strategies to minimize need for overly frequent (i.e., annual) biopsies, including potential role of multiparametric MRIs and new biomarkers, as also whether active surveillance is appropriate for a subset of men with Gleason 3 + 4 = 7 disease who have a very small volume Gleason pattern 4 disease.
On the panel were Mike Scott, Thomas N. Krik, Tony Crispino and Walter Green Jr.
Yuval Neria, PhD, Director of The Trauma and PTSD Program at Columbia University Medical Center
Emily Joyner, BA, Research Coordinator for Trauma and PTSD Program
1. What is PTSD
2. Who may develop PTSD (war vets; dis survivors; rape victims)
3. Are there biomarkers that can predict PTSD, and recovery from PTSD
4. What are the best treatments
Contact information about research studies: http://www.columbiatrauma.org/ or call 646 774-8104
To listen to any of Columbia Psychiatry's archived shows on assorted topics such as OCD, eating disorders or substance abuse, please go to blogtalkradio.com/columbiapsychiatrynyspi
Celebrity interviews regarding obesity and its relation to dementia, anti aging, arthritis, cancer and heart disease. The Dr. Repices' host the show and talk about life style changes for a healthier and longer life. Are you worried about dementia, heart disease? Call in to our show or just listen.
Today ww will start a discussion of predictive biomarkers.
Our incredible special guest tonight is Dr. Diana Rosas, MD, Director, Center for Neuro-Imaging of Aging and Neurodegenerative Disease. Dr. Rosas and her team have focused primarily on the development of biomarkers for use in the study of neurodegenerative diseases, to better characterize progression, to better understand genotype/phenotype correlations and to apply novel neuroimaging approaches in clinical trials with the overall aim of making them more efficient.
Dr. Rosas’ lab has begun to develop models that may explain clinically heterogeneous phenotypes and variability in disease progression. The current models for both disease prediction and prediction of disease progression are insensitive and inaccurate. Dr. Rosas is planning to expand her efforts to include multi-modal and multi-spectral imaging approaches that promise both more precise measurements and may provide novel and important information on the neural underpinnings of HD and their clinical consequences.
Dr. Rosas is Co-Principal Investigator for the CREST-E Study. CREST-E stands for Creatine Safety, Tolerability, & Efficacy in Huntington’s disease. The Huntington Study Group (HSG), in a partnership between Massachusetts General Hospital (MGH) and the University of Rochester, is conducting a global, multi-center, randomized, double-blind, placebo-controlled clinical trial in individuals 18 years of and older with Huntington’s disease (HD). Tonight is the third and final episode in the CREST-E Series. Tune in for another amazing episode about CREST-E.
Contact Dr. Diana Rosas
Today on Blue Zone Wellness join us for an interesting and insightful show.In our Week in Natural News Review Segment Dr. Henry would discuss and analyze a particular therapy that has been shown to work exceedingly well against infections without the use of antibiotics. You will be amazed at the simplicity and power of this therapy. Dr. Henry will also discuss and analyze an article which he didn't get an opportunity to get to in our last broadcast wherein he discusses how many procedures and tests have been shown to have very little if any benefit at all,but can cost you thousands of dollars.Finally Dr. Henry also discusses the ability of a specific kind of seaweed that performs better in shrinking breast cancer tumors than chemo.In the Healing Foods Segment Dr. Henry discusses how a vegetarian diet lowers blood pressure and improves blood lipid biomarkers to reduce heart disease risk. In this segment he also discusses some of the healing properties of the delicious mango. Not only is the mango delicious, but it's also extremely beneficial for your health!Finally in the Healing Herbs/Healing Supplement Segment Dr. Henry will continue his explanation on the function of minerals and vitamins in the body,the deficiency thereof, symptoms and the necessary amounts for health.
Sharry Edwards™ is the pioneer in the study of Human BioAcoustic Biology. Her 30 years of research is being used at the Institute of BioAcoustic Biology in Albany, OH, and is now included in The Duke University Encyclopedia of New Medicine, by Leonard A. Wisnecki and The Scientific Basis of Integrative Medicine, by Lucy Anderson. The effects of BioAcoustic Biology, now accepted by these prestigious medical encyclopedias, offers unlimited health and wellness potential.
Sharry is creator of NanoVoice™ a micro-version of our professional nVoice Personality Profiler™ which uses frequency-based biomarkers within the frequencies of your voice to allow you an enlightening peek into your Secret Self.
NanoVoice can help you understand and solve issues using unconscious levels of awareness. This innovative technology is the forefront of future wellness based on personal biofrequency correlations to emotional, genetic, structural and biochemical information about YOU.
Currently, Edwards and her team at Sound Health are using human voice and the associated frequencies to help clients resolve health issues such as: macular degeneration, multiple sclerosis, headaches, muscle stress, brain trauma, weight issues and nutritional concerns. The technology is cutting edge! This technology can identify health and well-being possibilities that you have never encounter.
Dr. Jay Lombard speaks with Joyce about the need for better ways to evaluate a person’s mental state and stability, and to determine what drugs or nutritional elements might be helpful for this particular individual. Good nutrition is essential to brain health. Individuals may have subtle deficiencies of essential minerals. There are thousands of drugs – which one is most likely to benefit this person?
Dr. Lombard, a board certified neurologist, has published several books on the role of nutrition and the brain and has lectured extensively on this topic.
The chief scientific officer of Genomind, Dr. Jay Lombard, says psychiatry needs objective biomarkers for diagnosis, and that solutions are on the way thanks to genetics, proteomics and epigenics.
1 minute overview: http://www.youtube.com/watch?v=Nb-HrOQRnLg
6 minute introduction to his philosophy: http://www.youtube.com/watch?v=HOy74jiyZuQ
More detailed presentation done for the NAMI.
Dr. Lombard has had numerous television and radio appearances including appearances on Larry King, Dr. Oz, CBS News, Fox News, The Early Morning Show and others. He was also invited to present at TEDMED 2012. He is currently a professor of Neurology at Touro College of Osteopathic Medicine.